What Is COVAX?
COVID-19 Vaccines Global Access, better known as COVAX, is a global platform to support the development, manufacturing, and distribution of COVID-19 vaccines. It was launched in April 2020 by the World Health Organization (WHO), the European Commission, and France as one of the three pillars of the Access to COVID-19 Tool Accelerator.
A crucial aspect of the initiative is the COVAX Facility, which is run by public-private global health partnership known as Gavi, the Vaccine Alliance. The COVAX Facility is a procurement mechanism that purchases vaccines from a portfolio of producers on behalf of countries that are COVAX members. The facility has been working with manufacturers to ensure that they had the capacity to produce large quantities of doses once vaccines were approved. Now, the facility is purchasing and distributing vaccines to its member countries.
Covid-19 vaccine: Second purchase from AstraZeneca via COVAX — Khairy theedgemarkets.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theedgemarkets.com Daily Mail and Mail on Sunday newspapers.
23 Dec 2020 / 22:00 H.
PUTRAJAYA: Malaysia had opted for the Covid-19 vaccine produced by United Kingdom (UK) pharmaceutical company AstraZeneca through negotiations under the COVAX facility that will ensure supply for another 10 per cent of the country’s population.
Science, Technology and Innovation Minister Khairy Jamaluddin said this will see supply from AstraZeneca increase to 20 per cent after an earlier procurement of 10 per cent through direct negotiation with the company.
“AstraZeneca’s delivery of the vaccine through COVAX is being finalised but we have been told it is between March and June next year.
“Through the direct negotiation, meanwhile, (Malaysia) will receive the first shipment in April or May 2021,” he told a media conference on the development to procure Covid-19 vaccines here, today.
DA to push for government’s vaccine plans to be released publicly
Issued by Siviwe Gwarube MP & Geordin Hill-Lewis MP –
18 Dec 2020 in News
Since the outbreak of the Covid-19 pandemic in Wuhan, China late 2019, the global medical fraternity has been working at record speed to develop a safe and reliable vaccine in laboratories across the world. The World Health Organisation’s CoVax Programme, of which South Africa is a participating member, has sought to ensure equitable access for all countries, regardless of their financial status.
Countless countries are scrambling to acquire the vaccine. Countless countries except one – South Africa. Securing the vaccine for South Africa as soon as possible should be the government’s number one priority right now. However, South Africa has missed the deadline for a deposit on the CoVax Vaccine Facility, not once, but twice.
South Africa: DA to Push for Govt s Vaccine Plans to Be Released Publicly allafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allafrica.com Daily Mail and Mail on Sunday newspapers.